comparemela.com

Latest Breaking News On - Nicolas fellmann - Page 1 : comparemela.com

Biophytis Announces the Design of its Phase 2 OBA Clinical Study in

Biophytis Announces the Design of its Phase 2 OBA Clinical Study in
pr-inside.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pr-inside.com Daily Mail and Mail on Sunday newspapers.

France generalUnited statesUnited kingdomAntoine denryNizar berradaNicolas fellmannNews networkExchange commissionEuronext growth parisWalking distancePatient reported outcomesInvestigational new drugEuronext growthAmerican depositary shares

Biophytis Announces the Design of its Phase 2 OBA Clinical Study in Obesity

Biophytis Announces the Design of its Phase 2 OBA Clinical Study in Obesity
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesFrance generalUnited kingdomNizar berradaAntoine denryNicolas fellmannExchange commissionEuronext growth parisWalking distancePatient reported outcomesInvestigational new drugEuronext growthAmerican depositary sharesChance des

Biophytis is deploying its partnership strategy in obesity

Biophytis / Key word(s): MiscellaneousBiophytis is deploying its partnership strategy in obesity 29-Apr-2024 / 14:39 CET/CESTBiophytis is deploying its partnership strategy in obesity Paris (France) and Cambridge (Massachusetts, USA), April 29, 2024 – 07:00 am CET – Biophytis SA (Euronext Growth Paris : ALBPS),.

San diegoUnited statesFrance generalUnited kingdomNizar berradaNicolas fellmannAntoine denryExchange commissionEuronext growth parisSenior managementEuronext growthAmerican depositary sharesFinancial wire news

Biophytis is Deploying its Partnership Strategy in Obesity

Biophytis is Deploying its Partnership Strategy in Obesity

United statesFrance generalUnited kingdomSan diegoNicolas fellmannNizar berradaNews networkExchange commissionEuronext growth parisSenior managementEuronext growthAmerican depositary shares

Biophytis is Deploying its Partnership Strategy in Obesity

PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / April 29, 2024 / Biophytis SA (Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specialized in the development of therapeutics for age-related diseases, today announces the implementation of a dedic.

United statesUnited kingdomFrance generalSan diegoNicolas fellmannNizar berradaExchange commissionEuronext growth parisSenior managementEuronext growthAmerican depositary shares

vimarsana © 2020. All Rights Reserved.